Soluble CD137 as a potential biomarker for severe COVID-19

por Marques, Mariana de Oliveira, Abdo, André, Silva, Priscilla Brito, Silva Junior, Amilton, Alves, Lucas Bassolli de Oliveira, Costa, José Victor Gomes, Martin, Josiane, Bachour, Philip, Baiocchi, Otavio C.G.
Publicado 2022

Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib, or nilotinib: A cohort study using data from a large multinational col...

por Nunes, Rafael Amorim Belo, Neves, Precil Diego Miranda de Menezes, da Costa, Leandro Menezes Alves, Bachour, Philip, Cantarelli, Marcelo José de Carvalho, Oliveira, Gustavo Bernardes de Figueiredo, Avezum Jr., Álvaro
Publicado 2023